Alan T. Villavicencio, MD

View CV

Dr. Villavicencio graduated with honors from Harvard Medical School in Boston, Massachusetts, in 1995 and completed a neurosurgical residency at Duke University Medical Center in Durham, North Carolina, in 2001. He then went on to an orthopedic spine surgery fellowship at Cedars-Sinai Medical Center in Los Angeles, California, in 2002, and is one of only a handful of surgeons in the country with dual neurosurgery and orthopedic spine training.

Dr. Villavicencio is board-certified by the American Board of Neurological Surgery (ABNS) and the senior practicing partner at Boulder Neurosurgical & Spine Associates (BNA). Dr. Villavicencio specializes in minimally invasive spine surgery as well as complex spinal reconstruction surgery, including treatment of scoliosis and other types of spinal deformity. He treats a majority of all brain and spinal disorders, including all variations of brain tumors, and performs approximately 500 operative cases each year.

Dr. Villavicencio is the Director of Research and Development for BNA, Director of Neurosurgery at Boulder Community and Longmont United Hospitals, as well as Director of Surgery at, and founder of, the Minimally Invasive Spine Institute in Colorado. He is a member of the American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS), North American Spine Society (NASS), Colorado Neurosurgical Society (CNS), Colorado Medical Society (CMS), and the AANS/CNS Section on Tumors and Section on Disorders of the Spine and Peripheral Nerves.

Dr. Villavicencio’s goal as a neurosurgeon is to advance the neurosurgical field through continued development and application of innovative nonsurgical and surgical treatment options, and to stay at the forefront of neurosurgical care. He is among a select group of neurosurgeons in the country who are dedicated to improving clinical outcomes and patient safety by promoting and implementing evidence-based medicine into clinical practice.

Dr. Villavicencio is the founder and current program chairman for an annual neurosurgical symposium entitled, “Current Techniques in the Treatment of Cranial and Spinal Disorders,” presented by BNA and the Justin Parker Neurological Institute (JPNI). The symposium began in 2004 and draws approximately 200 physicians and allied health care providers from throughout Colorado and other states each year. Dr. Villavicencio is also the founder and chairman of the board for the Justin Parker Neurological Institute, a fully accredited, tax-exempt 501(c)(3) nonprofit organization with an annual budget of approximately $250,000. The mission of JPNI is to advance scientific discoveries and innovative medical technologies into clinical practice by conducting clinical trials in order to implement best practices and disseminate this information to the medical community. JPNI also provides fellowship and internship opportunities to neurosurgical and orthopedic spine surgeons and students who are pursuing careers in medicine.

Dr. Villavicencio has presented hundreds of abstracts at national and international neurosurgical meetings. In addition, he has published more than 60 peer-reviewed articles and book chapters in leading neurosurgical journals and textbooks. Dr. Villavicencio also is principal investigator for several ongoing U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) prospective randomized trials.